Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Harnal Ocas - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Harnal Ocas

Approved

STANDARD

Harnal Ocas

Astellas Pharma Europe B.V.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 3cd25f7941cd77fd
Company: Astellas Pharma Europe B.V.
Type: Standard

Approval Details

Approval Id: 3cd25f7941cd77fd
Drug Approval Philippines Name: Harnal Ocas
Product Name: Harnal Ocas
Registration Number: DR-XY33041
Brand Name: Harnal Ocas
Generic Name: Tamsulosin Hydrochloride
Dosage Form: Prolonged Release Film-Coated Tablet
Dosage Strength: 400mcg
Manufacturer: Astellas Pharma Europe B.V.
Trader: none
Importer: Astellas Pharma Philippines, Inc.
Distributor: Zuellig Pharma Corporation
Company Detail Path: /organization/astellas-pharma-europe-b-v
Issuance Date: 26 April 2022
Expiry Date: 26 February 2027
Pharmacologic Category: Alpha-1 Adrenoceptor Antagonist
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

3cd25f7941cd77fd

Type

Standard

Back to Philippines FDA Approvals